drugset / Trial / NCT00306254

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

NCT00306254

Phase 2 Completed 1225 enrolled Pfizer
RandomizedParallel-groupDouble-blindPrevention

Summary

To study the safety and effectiveness of several doses of PD 0348292 compared to enoxaparin in preventing blood clots in the lungs or deep leg veins of patients after knee surgery

Timeline

Start
2006-03
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ERIBAXABAN Small molecule
Subject Enoxaparin sodium Other / unclassified